Pfizer has become the latest drugmaker taken to task for high prices after U.K. authorities hit the company with a record $107 million fine over the price of an anti-epilepsy drug.
WSJ.com: Law, Wall Street Journal: Business: Law
Wed, 12/07/2016 - 12:41pm
Pfizer has become the latest drugmaker taken to task for high prices after U.K. authorities hit the company with a record $107 million fine over the price of an anti-epilepsy drug.